It's actually incredibly harmful to Indians, the healthcare costs gained aren't much, medicines are licensed for a fraction of what consumers pay in the West.
Yet because of their incredibly weak IP protections many drug companies are reluctant to sell there. Hundreds of medicines simply aren't available despite being released a decade earlier and Indians in need have to pay European prices for access to modern pharmaceuticals. It's entirely destroyed any chance for local r&d too.
It's not a net benefit.
I'm all for sticking it to the Man and especially criticising big pharma but suggest reconsidering your viewpoint here.
Yet because of their incredibly weak IP protections many drug companies are reluctant to sell there. Hundreds of medicines simply aren't available despite being released a decade earlier and Indians in need have to pay European prices for access to modern pharmaceuticals. It's entirely destroyed any chance for local r&d too.
It's not a net benefit.
I'm all for sticking it to the Man and especially criticising big pharma but suggest reconsidering your viewpoint here.
https://www.forbes.com/sites/theapothecary/2014/09/09/indian...